| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.003 | 0.932 | Non-steroidal antiinflammatory agent | 0.759 0.003 CID_159665 0.932 0.002 CID_154699895 | CID_154699895 | |
| 0.67 | 0.002 | 0.838 | Cyclooxygenase 3 inhibitor | 0.662 0.002 CID_159665 0.838 0.001 CID_154699895 | CID_154699895 | |
| 0.589 | 0.004 | 0.619 | Prostaglandin antagonist | 0.619 0.003 CID_159665 0.14 0.011 CID_154699895 | CID_159665 | |
| 0.557 | 0.004 | 0.58 | NADPH oxidase inhibitor | 0.58 0.004 CID_159665 0.49 0.004 CID_154699895 | CID_159665 | |
| 0.603 | 0.053 | 0.786 | Antiinflammatory | 0.664 0.038 CID_159665 0.786 0.017 CID_154699895 | CID_154699895 | |
| 0.479 | 0.003 | 0.501 | Prostaglandin D2 antagonist | 0.501 0.003 CID_159665 0.047 0.007 CID_154699895 | CID_159665 | |
| 0.464 | 0.005 | 0.506 | Cyclooxygenase 1 inhibitor | 0.506 0.005 CID_159665 0.351 0.01 CID_154699895 | CID_159665 | |
| 0.486 | 0.036 | 0.486 | Thyroid hormone antagonist | 0.448 0.043 CID_159665 | ||
| 0.451 | 0.005 | 0.469 | Cyclooxygenase inhibitor | 0.469 0.005 CID_159665 0.36 0.01 CID_154699895 | CID_159665 | |
| 0.467 | 0.038 | 0.467 | Thyroid hormone beta antagonist | 0.418 0.048 CID_159665 | ||
| 0.434 | 0.013 | 0.462 | Anesthetic general | 0.462 0.01 CID_159665 0.377 0.019 CID_154699895 | CID_159665 | |
| 0.423 | 0.014 | 0.43 | Cyclic AMP phosphodiesterase inhibitor | 0.42 0.014 CID_159665 0.43 0.013 CID_154699895 | CID_154699895 | |
| 0.406 | 0.006 | 0.406 | Insulin sensitizer | 0.402 0.006 CID_159665 0.252 0.033 CID_154699895 | ||
| 0.4 | 0.004 | 0.43 | Prostaglandin EP2 antagonist | 0.43 0.004 CID_159665 0.218 0.005 CID_154699895 | CID_159665 | |
| 0.389 | 0.005 | 0.407 | Phospholipase A2 inhibitor | 0.407 0.005 CID_159665 0.311 0.012 CID_154699895 | CID_159665 | |
| 0.384 | 0.004 | 0.501 | Histidine decarboxylase inhibitor | 0.501 0.003 CID_159665 | CID_159665 | |
| 0.378 | 0.007 | 0.388 | Cyclooxygenase 2 inhibitor | 0.388 0.006 CID_159665 0.305 0.013 CID_154699895 | CID_159665 | |
| 0.374 | 0.035 | 0.374 | Calcium channel activator | 0.329 0.065 CID_159665 | ||
| 0.373 | 0.044 | 0.401 | Lipoxygenase inhibitor | 0.401 0.037 CID_159665 | CID_159665 | |
| 0.379 | 0.055 | 0.627 | Antithrombotic | 0.417 0.045 CID_159665 0.627 0.014 CID_154699895 | CID_154699895 | |
| 0.388 | 0.065 | 0.406 | Toll-Like receptor 7 agonist | 0.406 0.058 CID_159665 | CID_159665 | |
| 0.385 | 0.067 | 0.402 | Toll-Like receptor agonist | 0.402 0.059 CID_159665 | CID_159665 | |
| 0.371 | 0.108 | 0.601 | Cyclophilin D inhibitor | 0.414 0.084 CID_159665 0.601 0.027 CID_154699895 | CID_154699895 | |
| 0.308 | 0.072 | 0.336 | Sodium/bile acid cotransporter inhibitor | 0.336 0.049 CID_159665 | CID_159665 | |
| 0.233 | 0.003 | 0.247 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.247 0.003 CID_159665 | CID_159665 | |
| 0.228 | 0.004 | 0.228 | Peroxisome proliferator-activated receptor gamma antagonist | 0.174 0.005 CID_159665 0.078 0.036 CID_154699895 | ||
| 0.296 | 0.076 | 0.427 | Interleukin 2 agonist | 0.349 0.046 CID_159665 0.427 0.02 CID_154699895 | CID_154699895 | |
| 0.265 | 0.046 | 0.265 | Platelet aggregation inhibitor | 0.195 0.084 CID_159665 | ||
| 0.28 | 0.076 | 0.28 | Hypoxia-inducible factor 1 alpha inhibitor | 0.28 0.076 CID_159665 0.25 0.1 CID_154699895 | ||
| 0.295 | 0.097 | 0.706 | Transcription factor NF kappa B inhibitor | 0.346 0.078 CID_159665 0.706 0.02 CID_154699895 | CID_154699895 | |
| 0.226 | 0.032 | 0.233 | Succinate dehydrogenase inhibitor | 0.233 0.029 CID_159665 | CID_159665 | |
| 0.232 | 0.042 | 0.277 | Mcl-1 antagonist | 0.277 0.027 CID_159665 0.123 0.121 CID_154699895 | CID_159665 | |
| 0.192 | 0.006 | 0.192 | Amidase inhibitor | 0.192 0.006 CID_159665 | ||
| 0.258 | 0.072 | 0.466 | Hypoglycemic | 0.279 0.061 CID_159665 0.466 0.019 CID_154699895 | CID_154699895 | |
| 0.221 | 0.037 | 0.394 | Amylase inhibitor | 0.257 0.026 CID_159665 0.394 0.009 CID_154699895 | CID_154699895 | |
| 0.255 | 0.074 | 0.255 | Gastrin inhibitor | 0.254 0.075 CID_159665 | ||
| 0.192 | 0.015 | 0.258 | Interleukin 8 antagonist | 0.258 0.005 CID_159665 | CID_159665 | |
| 0.211 | 0.04 | 0.294 | Diuretic | 0.294 0.023 CID_159665 0.181 0.053 CID_154699895 | CID_159665 | |
| 0.168 | 0.007 | 0.174 | Prostaglandin E2 antagonist | 0.174 0.007 CID_159665 | CID_159665 | |
| 0.169 | 0.009 | 0.169 | Peroxisome proliferator-activated receptor gamma agonist | 0.164 0.01 CID_159665 0.084 0.038 CID_154699895 | ||
| 0.163 | 0.007 | 0.179 | Cannabinoid CB2 receptor antagonist | 0.179 0.006 CID_159665 | CID_159665 | |
| 0.308 | 0.156 | 0.326 | 5 Hydroxytryptamine release inhibitor | 0.326 0.138 CID_159665 0.261 0.213 CID_154699895 | CID_159665 | |
| 0.176 | 0.031 | 0.238 | Cystathionine beta-synthase inhibitor | 0.238 0.017 CID_159665 0.093 0.085 CID_154699895 | CID_159665 | |
| 0.227 | 0.083 | 0.365 | Antiamyloidogenic | 0.223 0.084 CID_159665 0.365 0.036 CID_154699895 | CID_154699895 | |
| 0.187 | 0.046 | 0.2 | Arachidonic acid antagonist | 0.2 0.033 CID_159665 | CID_159665 | |
| 0.297 | 0.16 | 0.37 | Calcium channel L-type activator | 0.37 0.103 CID_159665 | CID_159665 | |
| 0.21 | 0.075 | 0.222 | Psychostimulant | 0.222 0.069 CID_159665 | CID_159665 | |
| 0.286 | 0.153 | 0.39 | Analgesic | 0.39 0.089 CID_159665 | CID_159665 | |
| 0.144 | 0.016 | 0.155 | Cannabinoid receptor antagonist | 0.155 0.014 CID_159665 | CID_159665 | |
| 0.266 | 0.144 | 0.347 | Histamine release inhibitor | 0.347 0.101 CID_159665 0.293 0.127 CID_154699895 | CID_159665 | |
| 0.233 | 0.114 | 0.298 | Insulysin inhibitor | 0.298 0.06 CID_159665 | CID_159665 | |
| 0.148 | 0.038 | 0.183 | 5-Lipoxygenase inhibitor | 0.183 0.028 CID_159665 | CID_159665 | |
| 0.206 | 0.097 | 0.268 | Platelet antagonist | 0.214 0.092 CID_159665 0.268 0.065 CID_154699895 | CID_154699895 | |
| 0.122 | 0.016 | 0.133 | Sphingosine 1-phosphate receptor 4 agonist | 0.133 0.012 CID_159665 | CID_159665 | |
| 0.137 | 0.032 | 0.191 | Potassium channel (Ca-activated) activator | 0.191 0.016 CID_159665 | CID_159665 | |
| 0.119 | 0.014 | 0.159 | Aldose reductase inhibitor | 0.159 0.01 CID_159665 0.076 0.025 CID_154699895 | CID_159665 | |
| 0.206 | 0.102 | 0.292 | Aldehyde oxidase inhibitor | 0.292 0.068 CID_159665 | CID_159665 | |
| 0.111 | 0.01 | 0.126 | GABA B receptor agonist | 0.126 0.006 CID_159665 | CID_159665 | |
| 0.135 | 0.034 | 0.195 | Multidrug resistance-associated protein 1 inhibitor | 0.128 0.04 CID_159665 0.195 0.012 CID_154699895 | CID_154699895 | |
| 0.284 | 0.184 | 0.588 | Apoptosis agonist | 0.295 0.176 CID_159665 0.588 0.052 CID_154699895 | CID_154699895 | |
| 0.119 | 0.021 | 0.13 | Bile acid receptor antagonist | 0.13 0.013 CID_159665 | CID_159665 | |
| 0.296 | 0.198 | 0.387 | Caspase 9 stimulant | 0.262 0.239 CID_159665 0.387 0.119 CID_154699895 | CID_154699895 | |
| 0.135 | 0.037 | 0.141 | Sphingosine 1-phosphate receptor 2 agonist | 0.141 0.032 CID_159665 | CID_159665 | |
| 0.139 | 0.045 | 0.139 | Sphingosine 1-phosphate receptor 4 antagonist | 0.132 0.053 CID_159665 | ||
| 0.166 | 0.073 | 0.182 | Catenin beta inhibitor | 0.182 0.05 CID_159665 | CID_159665 | |
| 0.231 | 0.139 | 0.397 | Cholesterol antagonist | 0.262 0.117 CID_159665 0.397 0.05 CID_154699895 | CID_154699895 | |
| 0.095 | 0.007 | 0.095 | Calcium channel P-type blocker | 0.062 0.052 CID_159665 | ||
| 0.166 | 0.078 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | 0.142 0.115 CID_159665 | ||
| 0.102 | 0.016 | 0.122 | Cannabinoid CB1 receptor antagonist | 0.122 0.011 CID_159665 | CID_159665 | |
| 0.132 | 0.046 | 0.153 | TRPA1 agonist | 0.153 0.029 CID_159665 | CID_159665 | |
| 0.203 | 0.118 | 0.28 | Interleukin agonist | 0.239 0.087 CID_159665 0.28 0.059 CID_154699895 | CID_154699895 | |
| 0.106 | 0.023 | 0.111 | Leukotriene synthesis inhibitor | 0.111 0.02 CID_159665 | CID_159665 | |
| 0.123 | 0.042 | 0.184 | DOPA decarboxylase inhibitor | 0.184 0.009 CID_159665 | CID_159665 | |
| 0.111 | 0.029 | 0.135 | Cathepsin G inhibitor | 0.135 0.024 CID_159665 | CID_159665 | |
| 0.142 | 0.062 | 0.142 | Tubulin antagonist | |||
| 0.177 | 0.098 | 0.239 | Interleukin antagonist | 0.239 0.066 CID_159665 | CID_159665 | |
| 0.132 | 0.055 | 0.146 | Cholesterol synthesis inhibitor | 0.146 0.046 CID_159665 | CID_159665 | |
| 0.209 | 0.135 | 0.229 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 CID_159665 | CID_159665 | |
| 0.097 | 0.023 | 0.097 | Leukotriene antagonist | 0.093 0.025 CID_159665 0.057 0.054 CID_154699895 | ||
| 0.239 | 0.167 | 0.265 | Antiobesity | 0.265 0.144 CID_159665 | CID_159665 | |
| 0.075 | 0.009 | 0.075 | Carnitine palmitoyltransferase 1B inhibitor | 0.064 0.015 CID_159665 | ||
| 0.12 | 0.054 | 0.12 | Mucolytic | 0.111 0.063 CID_159665 0.112 0.062 CID_154699895 | ||
| 0.076 | 0.013 | 0.077 | DNA helicase inhibitor | 0.077 0.013 CID_159665 | CID_159665 | |
| 0.134 | 0.075 | 0.159 | Farnesoid X receptor antagonist | 0.159 0.043 CID_159665 | CID_159665 | |
| 0.188 | 0.132 | 0.21 | 5 Hydroxytryptamine release stimulant | 0.21 0.113 CID_159665 | CID_159665 | |
| 0.103 | 0.047 | 0.104 | ABCA1 expression enhancer | 0.104 0.045 CID_159665 | CID_159665 | |
| 0.154 | 0.099 | 0.202 | Phospholipase C inhibitor | 0.202 0.043 CID_159665 | CID_159665 | |
| 0.069 | 0.015 | 0.076 | Leukotriene C antagonist | 0.076 0.01 CID_159665 | CID_159665 | |
| 0.075 | 0.023 | 0.091 | Thromboxane antagonist | 0.091 0.014 CID_159665 | CID_159665 | |
| 0.072 | 0.021 | 0.072 | Peroxisome proliferator-activated receptor alpha agonist | 0.042 0.039 CID_159665 | ||
| 0.151 | 0.1 | 0.169 | Neurotensin receptor agonist | 0.169 0.064 CID_159665 | CID_159665 | |
| 0.081 | 0.031 | 0.096 | Bcl2 antagonist | 0.096 0.02 CID_159665 | CID_159665 | |
| 0.169 | 0.119 | 0.191 | Hypolipemic | 0.18 0.109 CID_159665 0.191 0.101 CID_154699895 | CID_154699895 | |
| 0.101 | 0.053 | 0.103 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.103 0.051 CID_159665 0.095 0.059 CID_154699895 | CID_159665 | |
| 0.054 | 0.008 | 0.054 | Peroxisome proliferator-activated receptor alpha antagonist | 0.034 0.01 CID_159665 | ||
| 0.053 | 0.008 | 0.053 | Prostaglandin EP4 antagonist | 0.049 0.009 CID_159665 | ||
| 0.053 | 0.009 | 0.053 | Peroxisome proliferator-activated receptor delta antagonist | 0.053 0.009 CID_159665 | ||
| 0.198 | 0.154 | 0.234 | 12-Lipoxygenase inhibitor | 0.234 0.119 CID_159665 | CID_159665 | |
| 0.154 | 0.11 | 0.185 | P-glycoprotein inhibitor | 0.185 0.075 CID_154699895 | CID_154699895 | |
| 0.074 | 0.03 | 0.076 | MDM2 inhibitor | 0.076 0.025 CID_159665 | CID_159665 | |
| 0.057 | 0.014 | 0.065 | Liver X receptor alpha agonist | 0.065 0.01 CID_159665 | CID_159665 | |
| 0.054 | 0.012 | 0.055 | p53 inhibitor | 0.055 0.011 CID_159665 | CID_159665 | |
| 0.078 | 0.036 | 0.101 | Potassium channel large-conductance Ca-activated activator | 0.101 0.023 CID_159665 | CID_159665 | |
| 0.048 | 0.008 | 0.05 | Prostaglandin D2 agonist | 0.05 0.008 CID_159665 0.031 0.02 CID_154699895 | CID_159665 | |
| 0.135 | 0.096 | 0.143 | Heat shock protein 70 antagonist | 0.143 0.065 CID_159665 | CID_159665 | |
| 0.135 | 0.096 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.069 CID_159665 | CID_159665 | |
| 0.043 | 0.005 | 0.074 | Thyroid hormone agonist | 0.074 0.003 CID_159665 | CID_159665 | |
| 0.047 | 0.01 | 0.047 | Carnitine palmitoyltransferase inhibitor | |||
| 0.046 | 0.01 | 0.046 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.051 | 0.018 | 0.073 | Urate transporter 1 inhibitor | 0.073 0.009 CID_159665 | CID_159665 | |
| 0.046 | 0.014 | 0.052 | Leukotriene C4 antagonist | 0.052 0.009 CID_159665 | CID_159665 | |
| 0.06 | 0.028 | 0.075 | Thromboxane A2 antagonist | 0.075 0.018 CID_159665 | CID_159665 | |
| 0.043 | 0.013 | 0.043 | Prostaglandin EP3 antagonist | 0.043 0.012 CID_159665 | ||
| 0.174 | 0.143 | 0.188 | Nitric-oxide synthase stimulant | 0.188 0.11 CID_159665 | CID_159665 | |
| 0.066 | 0.037 | 0.078 | Prostaglandin F2 alpha antagonist | 0.078 0.024 CID_159665 | CID_159665 | |
| 0.087 | 0.059 | 0.099 | Interleukin 5 antagonist | 0.099 0.043 CID_159665 | CID_159665 | |
| 0.057 | 0.03 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.029 CID_159665 | CID_159665 | |
| 0.056 | 0.029 | 0.084 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 CID_159665 0.084 0.01 CID_154699895 | CID_154699895 | |
| 0.033 | 0.009 | 0.036 | Prostaglandin EP1 antagonist | 0.036 0.009 CID_159665 | CID_159665 | |
| 0.062 | 0.038 | 0.097 | Androgen agonist | 0.097 0.016 CID_159665 | CID_159665 | |
| 0.037 | 0.014 | 0.053 | Liver X receptor beta antagonist | 0.053 0.007 CID_159665 | CID_159665 | |
| 0.043 | 0.02 | 0.043 | Farnesoid X receptor agonist | 0.036 0.028 CID_159665 | ||
| 0.026 | 0.005 | 0.041 | Thyroid hormone alpha antagonist | 0.041 0.004 CID_159665 | CID_159665 | |
| 0.024 | 0.005 | 0.03 | Thyroid hormone alpha agonist | 0.03 0.004 CID_159665 | CID_159665 | |
| 0.033 | 0.014 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 CID_159665 | CID_159665 | |
| 0.037 | 0.019 | 0.037 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.035 | 0.02 | 0.042 | Liver X receptor beta agonist | 0.042 0.014 CID_159665 | CID_159665 | |
| 0.054 | 0.039 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 CID_159665 | CID_159665 | |
| 0.042 | 0.028 | 0.043 | Kainate receptor agonist | 0.043 0.024 CID_159665 | CID_159665 | |
| 0.044 | 0.03 | 0.143 | NMDA receptor subunit 3B antagonist | 0.143 0.007 CID_159665 | CID_159665 | |
| 0.126 | 0.112 | 0.138 | Pregnane X receptor agonist | 0.138 0.077 CID_159665 | CID_159665 | |
| 0.085 | 0.073 | 0.109 | Uric acid excretion stimulant | 0.109 0.045 CID_159665 0.097 0.056 CID_154699895 | CID_159665 | |
| 0.066 | 0.054 | 0.088 | Prostaglandin-E synthase inhibitor | 0.088 0.034 CID_159665 | CID_159665 | |
| 0.079 | 0.068 | 0.079 | Factor XII inhibitor | |||
| 0.075 | 0.064 | 0.075 | MAP kinase 7 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.028 | 0.02 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.03 | 0.023 | 0.035 | Liver X receptor antagonist | 0.035 0.017 CID_159665 | CID_159665 | |
| 0.052 | 0.046 | 0.052 | Potassium channel Kv1.5 blocker | |||
| 0.01 | 0.005 | 0.03 | Thyroid hormone beta agonist | 0.03 0.003 CID_159665 | CID_159665 | |
| 0.067 | 0.062 | 0.074 | Glycine receptor agonist | 0.074 0.048 CID_159665 | CID_159665 | |
| 0.175 | 0.172 | 0.209 | Neuropeptide Y2 antagonist | 0.209 0.105 CID_159665 | CID_159665 | |
| 0.05 | 0.047 | 0.05 | Beta tubulin antagonist | |||
| 0.097 | 0.095 | 0.18 | Cell adhesion inhibitor | 0.18 0.031 CID_154699895 | CID_154699895 | |
| 0.134 | 0.132 | 0.14 | Lipocortins synthesis antagonist | 0.14 0.121 CID_159665 | CID_159665 | |
| 0.13 | 0.129 | 0.13 | DNA methyltransferase I inhibitor | |||
| 0.033 | 0.033 | 0.033 | Glutamate (mGluR3) antagonist | 0.033 0.031 CID_159665 | CID_159665 | |
| 0.028 | 0.029 | 0.049 | ATP citrate lysase inhibitor | 0.049 0.008 CID_159665 | CID_159665 | |
| 0.088 | 0.089 | 0.174 | AMP-activated protein kinase stimulant | 0.112 0.057 CID_159665 0.174 0.016 CID_154699895 | CID_154699895 | |
| 0.116 | 0.118 | 0.159 | Insulin secretagoues | 0.118 0.114 CID_159665 0.159 0.065 CID_154699895 | CID_154699895 | |
| 0.053 | 0.056 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 CID_159665 | CID_159665 | |
| 0.077 | 0.079 | 0.09 | D-Ala-D-Ala ligase inhibitor | 0.09 0.045 CID_159665 | CID_159665 | |
| 0.033 | 0.037 | 0.062 | Kainate receptor antagonist | 0.062 0.015 CID_159665 | CID_159665 | |
| 0.177 | 0.182 | 0.247 | Tyrosine 3 hydroxylase inhibitor | 0.247 0.071 CID_159665 | CID_159665 | |
| 0.084 | 0.09 | 0.195 | Expectorant | 0.195 0.021 CID_154699895 | CID_154699895 | |
| 0.028 | 0.038 | 0.102 | NMDA receptor subunit 3A antagonist | 0.102 0.008 CID_159665 | CID_159665 | |
| 0.128 | 0.138 | 0.149 | Pyruvate kinase inhibitor | 0.149 0.116 CID_159665 | CID_159665 | |
| 0.052 | 0.064 | 0.077 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.077 0.021 CID_159665 | CID_159665 | |
| 0.047 | 0.06 | 0.056 | Glucagon-like peptide 1 agonist | 0.056 0.051 CID_159665 | CID_159665 | |
| 0.197 | 0.211 | 0.383 | GABA C receptor rho-3 antagonist | 0.383 0.069 CID_159665 | CID_159665 | |
| 0.12 | 0.134 | 0.175 | Interferon gamma antagonist | 0.135 0.101 CID_159665 0.175 0.053 CID_154699895 | CID_154699895 | |
| 0.122 | 0.138 | 0.136 | CF transmembrane conductance regulator agonist | 0.136 0.104 CID_159665 0.128 0.122 CID_154699895 | CID_159665 | |
| 0.116 | 0.134 | 0.131 | Dual specificity phosphatase 3 inhibitor | 0.131 0.115 CID_159665 | CID_159665 | |
| 0.108 | 0.13 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.103 CID_159665 | CID_159665 | |
| 0.077 | 0.1 | 0.098 | Xanthine oxidase inhibitor | 0.098 0.061 CID_159665 0.093 0.067 CID_154699895 | CID_159665 | |
| 0.12 | 0.145 | 0.323 | Platelet adhesion inhibitor | 0.323 0.027 CID_154699895 | CID_154699895 | |
| 0.061 | 0.086 | 0.073 | Macrophage migration inhibitory factor inhibitor | 0.073 0.061 CID_159665 | CID_159665 | |
| 0.065 | 0.093 | 0.077 | Sphingosine 1-phosphate receptor antagonist | 0.077 0.052 CID_159665 | CID_159665 | |
| 0.013 | 0.043 | 0.024 | NMDA receptor glycine site antagonist | 0.024 0.018 CID_159665 | CID_159665 | |
| 0.041 | 0.075 | 0.074 | Heparanase inhibitor | 0.074 0.009 CID_154699895 | CID_154699895 | |
| 0.061 | 0.095 | 0.104 | Cell adhesion molecule inhibitor | 0.104 0.032 CID_154699895 | CID_154699895 | |
| 0.112 | 0.15 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 CID_159665 | CID_159665 | |
| 0.075 | 0.113 | 0.096 | GABA C receptor rho-1 antagonist | 0.096 0.067 CID_159665 | CID_159665 | |
| 0.045 | 0.084 | 0.061 | NMDA receptor agonist | 0.061 0.046 CID_159665 | CID_159665 | |
| 0.123 | 0.162 | 0.154 | ATPase inhibitor | 0.154 0.095 CID_154699895 | CID_154699895 | |
| 0.174 | 0.216 | 0.233 | Caspase 3 stimulant | 0.233 0.128 CID_154699895 | CID_154699895 | |
| 0.104 | 0.147 | 0.196 | Hexokinase inhibitor | 0.131 0.103 CID_159665 0.196 0.038 CID_154699895 | CID_154699895 | |
| 0.064 | 0.109 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.074 CID_159665 | CID_159665 | |
| 0.115 | 0.162 | 0.158 | DNA methylase inhibitor | 0.158 0.111 CID_154699895 | CID_154699895 | |
| 0.04 | 0.093 | 0.074 | Nitric oxide donor | 0.074 0.029 CID_154699895 | CID_154699895 | |
| 0.022 | 0.078 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 CID_159665 | CID_159665 | |
| 0.05 | 0.107 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.052 CID_159665 | CID_159665 | |
| 0.064 | 0.122 | 0.121 | NADH dehydrogenase inhibitor | 0.079 0.076 CID_159665 0.121 0.028 CID_154699895 | CID_154699895 | |
| 0.106 | 0.165 | 0.293 | Nitric oxide antagonist | 0.293 0.042 CID_154699895 | CID_154699895 | |
| 0.067 | 0.127 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | 0.093 0.067 CID_159665 | CID_159665 | |
| 0.088 | 0.149 | 0.21 | Thrombolytic | 0.21 0.047 CID_154699895 | CID_154699895 | |
| 0.04 | 0.103 | 0.055 | Purinergic P2X1 antagonist | 0.055 0.052 CID_159665 | CID_159665 | |
| 0.12 | 0.186 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.114 CID_159665 | CID_159665 | |
| 0.128 | 0.195 | 0.453 | Antioxidant | 0.184 0.128 CID_159665 0.453 0.026 CID_154699895 | CID_154699895 | |
| 0.021 | 0.088 | 0.071 | NMDA 2A receptor antagonist | 0.071 0.024 CID_159665 | CID_159665 | |
| 0.084 | 0.153 | 0.12 | Interleukin 4 antagonist | 0.119 0.087 CID_159665 0.12 0.086 CID_154699895 | CID_154699895 | |
| 0.034 | 0.105 | 0.052 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.052 0.051 CID_159665 | CID_159665 | |
| 0.104 | 0.176 | 0.134 | Melanin inhibitor | 0.134 0.107 CID_154699895 | CID_154699895 | |
| 0.08 | 0.153 | 0.128 | Estrogen antagonist | 0.128 0.041 CID_159665 | CID_159665 | |
| 0.071 | 0.145 | 0.165 | Toll-Like receptor 4 antagonist | 0.165 0.014 CID_154699895 | CID_154699895 | |
| 0.05 | 0.126 | 0.124 | NMDA receptor antagonist | 0.124 0.034 CID_159665 | CID_159665 | |
| 0.04 | 0.124 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 CID_154699895 | CID_154699895 | |
| 0.028 | 0.113 | 0.275 | Selectin antagonist | 0.275 0.007 CID_154699895 | CID_154699895 | |
| 0.063 | 0.148 | 0.105 | M18 aspartyl aminopeptidase inhibitor | 0.105 0.086 CID_159665 | CID_159665 | |
| 0.043 | 0.129 | 0.058 | Lipocortins synthesis agonist | 0.058 0.04 CID_154699895 | CID_154699895 | |
| 0.059 | 0.148 | 0.094 | Ferrochelatase inhibitor | 0.094 0.078 CID_159665 | CID_159665 | |
| 0.072 | 0.168 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 CID_159665 | CID_159665 | |
| 0.147 | 0.244 | 0.318 | Vasodilator, coronary | 0.318 0.074 CID_154699895 | CID_154699895 | |
| 0.044 | 0.144 | 0.17 | Monophenol monooxygenase inhibitor | 0.17 0.04 CID_154699895 | CID_154699895 | |
| 0.159 | 0.26 | 0.211 | 15-Lipoxygenase inhibitor | 0.211 0.201 CID_159665 | CID_159665 | |
| 0.15 | 0.255 | 0.435 | Immunosuppressant | 0.435 0.052 CID_154699895 | CID_154699895 | |
| 0.109 | 0.216 | 0.171 | Neurotrophic factor enhancer | 0.171 0.109 CID_159665 | CID_159665 | |
| 0.094 | 0.205 | 0.299 | Hepatoprotectant | 0.299 0.03 CID_154699895 | CID_154699895 | |
| 0.017 | 0.129 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.015 CID_154699895 | CID_154699895 | |
| 0.152 | 0.268 | 0.349 | Apoptosis antagonist | 0.349 0.056 CID_154699895 | CID_154699895 | |
| 0.101 | 0.225 | 0.389 | Free radical scavenger | 0.149 0.146 CID_159665 0.389 0.031 CID_154699895 | CID_154699895 | |
| 0.057 | 0.186 | 0.19 | Beta glucuronidase inhibitor | 0.19 0.014 CID_154699895 | CID_154699895 | |
| 0.054 | 0.186 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.046 CID_159665 | CID_159665 | |
| 0.056 | 0.189 | 0.096 | GABA C receptor antagonist | 0.096 0.084 CID_159665 | CID_159665 | |
| 0.042 | 0.176 | 0.093 | Alcohol dehydrogenase inhibitor | 0.093 0.061 CID_159665 | CID_159665 | |
| 0.039 | 0.179 | 0.171 | Topoisomerase I inhibitor | 0.171 0.034 CID_154699895 | CID_154699895 | |
| 0.031 | 0.18 | 0.077 | Topoisomerase II alpha inhibitor | 0.077 0.055 CID_154699895 | CID_154699895 | |
| 0.045 | 0.195 | 0.083 | ATPase (Vacuolar H+) inhibitor | 0.083 0.072 CID_154699895 | CID_154699895 | |
| 0.007 | 0.161 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CID_154699895 | CID_154699895 | |
| 0.028 | 0.184 | 0.064 | Glutamate decarboxylase inhibitor | 0.064 0.063 CID_159665 | CID_159665 | |
| 0.064 | 0.231 | 0.127 | Peroxidase inhibitor | 0.127 0.094 CID_159665 | CID_159665 | |
| 0.125 | 0.296 | 0.486 | Alpha-glucosidase inhibitor | 0.486 0.085 CID_154699895 | CID_154699895 | |
| 0.051 | 0.225 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.035 CID_154699895 | CID_154699895 | |
| 0.024 | 0.199 | 0.064 | Porphobilinogen synthase inhibitor | 0.064 0.062 CID_159665 | CID_159665 | |
| 0.023 | 0.205 | 0.069 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.048 CID_159665 | CID_159665 | |
| 0.039 | 0.224 | 0.119 | Creatine kinase inhibitor | 0.119 0.041 CID_159665 | CID_159665 | |
| 0.06 | 0.251 | 0.144 | Anticoagulant | 0.144 0.086 CID_154699895 | CID_154699895 | |
| 0.017 | 0.219 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 CID_154699895 | CID_154699895 | |
| 0.008 | 0.215 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 CID_154699895 | CID_154699895 | |
| 0.061 | 0.273 | 0.171 | Cell wall synthesis inhibitor | 0.171 0.047 CID_154699895 | CID_154699895 | |
| 0.049 | 0.266 | 0.099 | Microtubule formation inhibitor | 0.099 0.092 CID_154699895 | CID_154699895 | |
| 0.069 | 0.286 | 0.171 | NOS3 expression enhancer | 0.171 0.055 CID_154699895 | CID_154699895 | |
| 0.072 | 0.29 | 0.15 | Hemostatic | 0.15 0.068 CID_154699895 | CID_154699895 | |
| 0.039 | 0.263 | 0.13 | Alkylator | 0.13 0.059 CID_154699895 | CID_154699895 | |
| 0.048 | 0.3 | 0.418 | Angiogenesis stimulant | 0.418 0.019 CID_154699895 | CID_154699895 | |
| 0.031 | 0.284 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 CID_154699895 | CID_154699895 | |
| 0.109 | 0.368 | 0.295 | Peptidyltransferase inhibitor | 0.295 0.026 CID_154699895 | CID_154699895 | |
| 0.01 | 0.28 | 0.097 | Antineoplastic antibiotic | 0.097 0.048 CID_154699895 | CID_154699895 | |
| 0.092 | 0.378 | 0.129 | CC chemokine 6 receptor antagonist | 0.129 0.076 CID_154699895 | CID_154699895 | |
| 0.049 | 0.353 | 0.354 | Immunostimulant | 0.354 0.063 CID_154699895 | CID_154699895 | |
| 0.059 | 0.368 | 0.238 | Vasodilator | 0.238 0.076 CID_154699895 | CID_154699895 | |
| 0.028 | 0.35 | 0.086 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 CID_154699895 | CID_154699895 | |
| 0.039 | 0.378 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 CID_154699895 | CID_154699895 | |
| 0.048 | 0.422 | 0.306 | Tumour necrosis factor alpha release inhibitor | 0.306 0.051 CID_154699895 | CID_154699895 | |
| 0.012 | 0.475 | 0.049 | Antibiotic Aminoglycoside-like | 0.049 0.014 CID_154699895 | CID_154699895 | |
| 0.053 | 0.564 | 0.257 | Immunomodulator | 0.257 0.109 CID_154699895 | CID_154699895 | |
| 0.042 | 0.587 | 0.509 | Antibacterial | 0.509 0.038 CID_154699895 | CID_154699895 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |